Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Rationale for LDH-targeted cancer immunotherapyTina B S Miholjcic, Heloise Halse, Mélodie Bonvalet, et al.Breast Cancer Research : BCR|August 11, 2018
High mammographic density in women is associated with protumor inflammationCecilia W Huo, Prue Hill, Grace Chew, et al.The Journal of Investigative Dermatology|October 4, 2019
A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod ResponseHeloise Halse, Franco Caramia, Catriona A McLean, et al.Journal for Immunotherapy of Cancer|June 26, 2020
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hotSimon P Keam, Heloise Halse, Thu Nguyen, et al.Nature Immunology|November 13, 2012
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cellsDaniel M Andrews, Lucy C Sullivan, Nikola Baschuk, et al.Clinical & Translational Immunology|May 8, 2020
High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancerMinyu Wang, Yu-Kuan Huang, Joseph Ch Kong, et al.Cell Reports. Medicine|November 18, 2020
CD103<sup>+</sup>CD8<sup>+</sup> T<sub>RM</sub> Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17Stéphanie Corgnac, Ines Malenica, Laura Mezquita, et al.Journal of Experimental & Clinical Cancer Research : CR|July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancersCapucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.Pageof 1